UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000020398
Receipt number R000016543
Scientific Title Regenerative medicine using bone marrow-derived mesenchymal cells for maxillomandibular bone defect.
Date of disclosure of the study information 2016/01/15
Last modified on 2023/02/23 13:38:54

No. Disposal Last modified on Item of update
1 Insert 2015/12/29 19:47:31
2 Update 2016/05/10 15:40:00 Name of primary person or sponsor
Institute
Department
Organization
Organization
Category of Funding Organization
3 Update 2016/05/10 15:40:46 Recruitment status
Anticipated trial start date
4 Update 2016/05/27 18:43:44 UMIN ID2
5 Update 2016/08/08 08:52:05 Last name of lead principal investigator
Last name of lead principal investigator
Email
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Email
6 Update 2017/07/10 16:03:51 Organization1
Tel1
Email1
7 Update 2017/07/10 16:04:31 Recruitment status
8 Update 2018/07/11 18:47:24 Key exclusion criteria
Key exclusion criteria
9 Update 2018/07/11 18:49:47 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Email
10 Update 2018/08/14 13:18:22 UMIN ID3
11 Update 2019/02/14 22:09:45 Key exclusion criteria
Key exclusion criteria
12 Update 2019/02/14 22:10:43 TEL
13 Update 2020/08/26 12:03:12 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
TEL
Email

Last name of contact person

Last name of contact person
Division name
Division name
Zip code
Address
TEL
Email
Division name
Division name
Organization
Organization
Address
Address
Tel
Email
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
14 Update 2020/08/26 12:06:11 Recruitment status
Date of IRB
Last follow-up date
15 Update 2023/02/23 13:27:52 URL releasing protocol
Number of participants that the trial has enrolled
16 Update 2023/02/23 13:36:17 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
17 Update 2023/02/23 13:38:54 1st name of lead principal investigator
Last name of lead principal investigator
TEL
Email
TEL